Related Experiment Video
Updated: Apr 27, 2026
Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
Published on: June 13, 2019
Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer
1Cancer Program, Institute of Health and Biomedical Innovation; Australian Prostate Cancer Research Centre-Queensland, Translational Research Institute, Queensland University of Technology, Brisbane, Queensland, Australia.
Abstract:
Large scale exome sequencing studies have revealed regions of the genome, which contribute to the castrate resistant prostate cancer (CRPC) phenotype. Such studies have identified mutations in genes, which may have diagnostic/prognostic potential, or which may be targeted therapeutically. Two of these genes include the androgen receptor (AR) and speckle-type POZ protein (SPOP) genes. However, the findings from these exome sequencing studies can only be translated therapeutically once the functional consequences of these mutations have been determined. Here, we highlight the recent study by An et al. which investigated the functional effects of mutations in the SPOP gene that were identified in the aforementioned exome sequencing studies, particularly in the context of SPOP-mediated degradation of the AR.
Insights
Recent studies identified mutations in the speckle-type POZ protein (SPOP) gene linked to castrate-resistant prostate cancer (CRPC). This research explores how SPOP mutations affect androgen receptor (AR) degradation, crucial for CRPC development.
Area of Science:
- Genomics
- Oncology
- Molecular Biology
Background:
- Large-scale exome sequencing studies have identified genomic regions associated with castrate-resistant prostate cancer (CRPC).
- Mutations in key genes like the androgen receptor (AR) and speckle-type POZ protein (SPOP) have been discovered, offering potential therapeutic targets.
- Understanding the functional impact of these genetic mutations is essential for clinical translation.
Purpose of the Study:
- To investigate the functional consequences of SPOP gene mutations identified in CRPC.
- To elucidate the role of SPOP mutations in the context of SPOP-mediated degradation of the androgen receptor (AR).
Main Methods:
- Functional analysis of SPOP mutations.
- Investigation of SPOP's role in AR degradation pathways.
Main Results:
- The study by An et al. provides functional insights into SPOP mutations found in CRPC.
- Specific SPOP mutations impact the degradation of the androgen receptor (AR).
Conclusions:
- SPOP mutations play a significant role in the CRPC phenotype by affecting AR regulation.
- Further research into SPOP function could lead to novel therapeutic strategies for prostate cancer.
Related Concept Videos
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
02:23Abnormal Proliferation
01:32RNA Splicing